Registro:

Referencias:

• McCormick, J.B., Fisher-Hoch, S.P., Lassa fever (2002) Curr. Top. Microbiol. Immunol, 262, pp. 75-109
• Enria, D.A., Briggiler, A.M., Sánchez, Z., Treatment of Argentine hemorrhagic fever (2008) Antivir. Res, 78, pp. 132-139
• Macher, A.M., Wolfe, M.S., Historical Lassa fever reports and 30-year clinical update (2006) Emerg. Infect. Dis, 12, pp. 835-836
• Jamieson, D.J., Kourtis, A.P., Bell, M., Rasmussen, S.A., Lymphocytic choriomeningitis virus: An emerging obstetric pathogen? (2006) Am. J. Obstet. Gynecol, 194, pp. 1532-1536
• Fisher, S.A., Graham, M.B., Kuehnert, M.J., Kotton, C.N., Srinivasan, A., Marty, F.M., Comer, J.A., DeMeo, D.L., Transmission of lymphocytic choriomeningiris virus by organ transplantation (2006) N. Engl. J. Med, 354, pp. 2235-2249. , LCMV in Transplant recipients investigation team
• Charrel, R.N., de Lamballerie, X., Zoonotic aspects of arenavirus infections (2010) Vet. Microbiol, 140, pp. 213-220
• McCormick, J.B., King, I.J., Webb, P.A., Scribner, C.L., Craven, R.B., Johnson, K.M., Elliot, L.H., Belmont-Williams, R., Lassa fever. Effective therapy with ribavirin (1986) N. Engl. J. Med, 314, pp. 20-26
• Peters, C.J., Human infection with arenaviruses in the Americas (2002) Curr. Top. Microbiol. Immunol, 262, pp. 65-74
• Fisher-Hoch, S.P., Ghorie, S., Parker, L., Huggins, J., Unexpected adverse reactions during a clinical trial in rural West Africa (1992) Antivir. Res, 19, pp. 139-147
• Enria, D.A., Maiztegui, J.I., Antiviral treatment of Argentine hemorrhagic fever (1994) Antivir. Res, 23, pp. 23-31
• Duffy, S., Shackelton, L.A., Holmes, E.C., Rates of evolutionary change in viruses: Patterns and determinants (2008) Nat. Rev. Genet, 9, pp. 257-276
• Sanjuán, R., Nebot, M.R., Chirico, N., Mansky, L.M., Belshaw, R., Viral mutation rates (2010) J. Virol, 84, pp. 9733-9748
• Coley, W., Kehn-Hall, K., van Duyne, R., Kashanchi, F., Novel HIV-1 therapeutics through targeting altered host cell pathways (2009) Expert Opin. Biol. Ther, 9, pp. 1369-1382
• Khattab, M.A., Targeting host factors: A novel rationale for the management of hepatitis C virus (2009) World J. Gastroenterol, 15, pp. 3472-3479
• Krumm, S.A., Ndungu, J.M., Yoon, J.J., Dochow, M., Sun, A., Natchus, M., Snyder, J.P., Plemper, R.K., Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases (2011) PLoS One, 6, pp. e20069
• Pastorino, B., Nougairede, A., Wurtz, N., Gould, E., de Lamballerie, X., Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs (2010) Antivir. Res, 87, pp. 281-294
• Albariño, C.G., Bergeron, E., Erickson, B.R., Khristova, M.L., Rollin, P.E., Nichol, S.T., Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing (2009) J. Virol, 83, pp. 5606-5614
• Emonet, S.F., Seregin, A.V., Yun, N.E., Poussard, A.L., Walker, A.G., de la Torre, J.C., Paessler, S., Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease (2011) J. Virol, 85, pp. 1473-1483
• Carnec, X., Baize, S., Reynard, S., Diancourt, L., Caro, V., Tordo, N., Bouloy, M., Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages (2011) J. Virol, 85, pp. 12093-12097
• Larson, R.A., Dai, D., Hosack, V.T., Tan, Y., Bolken, T.C., Hruby, D.E., Amberg, S.M., Identification of a broad-spectrum arenavirus entry inhibitor (2008) J. Virol, 82, pp. 10768-10775
• Lee, A.M., Rojek, J.M., Spiropoulou, C.F., Gundersen, A.T., Jin, W., Shaginian, A., York, J., Oldstone, M.B., Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses (2008) J. Biol. Chem, 283, pp. 18734-18742
• Capul, A.A., de la Torre, J.C., A cell-based luciferase assay amenable to high-throughput screening of arenavirus budding (2008) Virology, 382, pp. 107-114
• Friedel, C.C., Jurgen, H., Virus-Host interactomes and global models of virus-infected cells (2011) Trends Microbiol, 19, pp. 501-508
• Shaw, M.L., The host interactome of influenza virus presents new potential targets for antiviral drugs (2011) Res. Med. Virol, 21, pp. 358-369
• Tafforeau, L., Rabourdin-Combe, C., Lotteau, V., Virus-Human cell interactomes (2012) Methods Mol. Biol, 812, pp. 103-120
• Djavani, M., Crasta, O.R., Zhang, Y., Zapata, J.C., Sobral, B., Lechner, M.G., Bryant, J., Salvato, M.S., Gene expression in primate liver during viral hemorrhagic fever (2009) Virol. J, 6 (20), pp. 1-20+18
• Müller, S., Geffers, R., Günther, S., Analysis of gene expression in Lassa virus-infected HuH-7 cells (2007) J. Gen. Virol, 88, pp. 1568-1575
• Bowick, G.C., Fennewald, S.M., Elsom, B.L., Aronson, J.F., Luxon, B.A., Gorenstein, D.G., Herzog, N.K., Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections (2006) J. Virol, 80, pp. 10248-10252
• Bowick, G.C., Fennewald, S.M., Scott, E.P., Zhang, L., Elsom, B.L., Aronson, J.F., Spratt, H.M., Herzog, N.K., Identification of differentially activated cell-signaling networks associated with Pichinde virus pathogenesis by using systems kinomics (2007) J. Virol, 81, pp. 1923-1933
• García, C.C., Sepúlveda, C.S., Damonte, E.B., Novel therapeutic targets for arenavirus hemorrhagic fevers (2011) Future Virol, 6, pp. 27-44
• Emonet, S.E., Urata, S., de la Torre, J.C., Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies (2011) Virology, 411, pp. 416-425
• Lee, A.M., Pasquato, A., Kunz, S., Novel approaches in anti-arenaviral drug development (2011) Virology, 411, pp. 163-169
• Rojek, J.M., Kunz, S., Cell entry by human pathogenic arenaviruses (2008) Cell. Microbiol, 10, pp. 828-835
• Streeter, D.G., Witkowski, J.T., Khare, G.P., Sidwell, R.W., Bauer, R.J., Robins, R.K., Simon, L.N., Mechanism of action of 1-ß-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent (1973) Proc. Natl. Acad. Sci. USA, 70, pp. 1174-1178
• Leyssen, P., Balzarini, J., de Clercq, E., Neyts, J., The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase (2005) J. Virol, 79, pp. 1943-1947
• Graci, J.D., Cameron, C.E., Mechanisms of action of ribavirin against distinct viruses (2006) Rev. Med. Virol, 16, pp. 37-48
• Leyssen, P., de Clercq, E., Neyts, J., Molecular strategies to inhibit the replication of RNA viruses (2008) Antivir. Res, 78, pp. 9-25
• Ölschläger, S., Neyts, J., Günther, S., Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus (2011) Antivir. Res, 91, pp. 89-93
• Sepúlveda, C.S., García, C.C., Fascio, M.L., D'Accorso, N.B., Docampo Palacios, M.L., Pellón, R.F., Damonte, E.B., Inhibition of Junín virus RNA synthesis by an antiviral acridone derivative (2012) Antivir. Res, 96, pp. 16-22
• Ruiz-Jarabo, C.M., Ly, C., Domingo, E., de la Torre, J.C., Lethal mutagenesis of the prototype arenavirus lymphocytic choriomeningitis virus (LCMV) (2003) Virology, 308, pp. 37-47
• Moreno, H., Gallego, I., Sevilla, N., de la Torre, J.C., Domingo, E., Martín, V., Ribavirin can be mutagenic for arenaviruses (2011) J. Virol, 85, pp. 7246-7255
• Andrei, G., de Clercq, E., Molecular approaches for the treatment of hemorrhagic fever virus infections (1993) Antivir. Res, 22, pp. 45-75
• Minakawa, N., Takeda, T., Sasaki, T., Matsuda, A., Ueda, T., Nucleotides and nucleosides. 96. Synthesis and antitumor activity of 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives (1991) J. Med. Chem, 34, pp. 778-786
• Sintchak, M.D., Nimmesgern, E., The structure of inosine 5X-monophosphate dehydrogenase and the design of novel inhibitors (2000) Inmunopharmacology, 47, pp. 163-184
• Goodell, J.R., Madhok, A.A., Hiasa, H., Ferguson, D.M., Synthesis and evaluation of acridone-and acridone-based anti-herpes agents with topoisomerase activity (2006) Bioorg. Med. Chem, 14, pp. 5467-5480
• Lowden, C.T., Bastow, K.F., Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives (2003) Antivir. Res, 59, pp. 143-154
• Itoigawa, M., Ito, C., Wu, T.S., Enjo, F., Tokuda, H., Nishino, H., Furukawa, H., Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis (2003) Cancer Lett, 193, pp. 133-138
• Zarubaev, V.V., Slita, A.V., Krivitskaya, V.Z., Sirotkin, A.K., Kovalenko, A.L., Chatterjee, N.K., Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro (2003) Antivir. Res, 58, pp. 131-137
• Fujiwara, M., Okamoto, M., Okamoto, M., Watanabe, M., Machida, H., Shigeta, S., Konno, K., Baba, M., Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells (1999) Antivir. Res, 43, pp. 179-189
• Turpin, J.A., Buckheit Jr., R.W., Derse, D., Hollingshead, M., Williamson, K., Palamone, C., Osterling, M.C., Schaeffer, C.A., Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription (1998) Antimicrob. Agents Chemother, 42, pp. 487-494
• Tabarrini, O., Manfroni, G., Fravolini, A., Cecchetti, V., Sabatini, S., de Clercq, E., Rozenski, J., Paeshuyse, J., Synthesis and anti-BVDV activity of acridones as new potential antiviral agents (2006) J. Med. Chem, 49, pp. 2621-2627
• Manfroni, G., Paeshuyse, J., Massari, S., Zanoli, S., Gatto, B., Maga, G., Tabarrini, O., Neyts, J., Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: Identification of an NS3 helicase inhibitor (2009) J. Med. Chem, 52, pp. 3354-3365
• Stankiewicz-Drogon, A., Dörner, B., Erker, T., Boguszewska-Chachulska, A.M., Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication (2010) J. Med. Chem, 53, pp. 3117-3126
• Vispé, S., Vandenberghe, I., Robin, M., Annereau, J.P., Créancier, L., Pique, V., Galy, J.P., Bailly, C., Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome (2007) Biochem. Pharmacol, 73, pp. 1863-1872
• Watterson, S.H., Chen, P., Zhao, Y., Gu, H.H., Dhar, T.G., Xiao, Z., Ballentine, S.K., Rouleau, K.A., Acridone-Based inhibitors of inosine 5'-monophosphate dehydrogenase: Discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl) pyridin-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroxyacridine-3-carboxamide (BMS-566419) (2007) J. Med. Chem, 50, pp. 3730-3742
• Adams, A., Crystal structures of acridines complexed with nucleic acids (2002) Curr. Med. Chem, 9, pp. 1667-1675
• Sepúlveda, C.S., Fascio, M.L., Mazzucco, M.B., Palacios, M.L., Pellón, R.F., García, C.C., D'Accorso, N.B., Damonte, E.B., Synthesis and evaluation of N-substituted acridones as antiviral agents against hemorrhagic fever viruses (2008) Antivir. Chem. Chemother, 19, pp. 41-47
• Gowen, B.B., Wong, M.H., Larson, D., Ye, W., Jung, K.H., Sefing, E.J., Skirpstunas, R., Schneller, S.W., Development of a new Tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog (2010) PLoS One, 16, pp. e12760
• Guillerm, G., Guillerm, D., Vandenplas-Vitkowski, C., Glapski, C., de Clercq, E., Inactivation of S-adenosyl-L-homocysteine hydrolase with novel 5'-thioadenosine derivatives. Antiviral effects (2003) Bioorg. Med. Chem. Lett, 13, pp. 1649-1652
• Venables, J.P., Koh, C.S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L., Bramard, A., Durand, M., Multiple and specific mRNA processing targets for the major human hnRNP proteins (2008) Mol. Cell Biol, 28, pp. 6033-6043
• He, Y., Smith, R., Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B (2009) Cell. Mol. Life Sci, 66, pp. 1239-1256
• Han, S.P., Tang, Y.H., Smith, R., Functional diversity of the hnRNPs: Past, present and perspectives (2010) Biochem. J, 430, pp. 379-392
• Castilla, V., Scolaro, L.A., Involvement of heterogeneous nuclear ribonucleoproteins in viral multiplication (2012) Future Virol, 7, pp. 575-591
• Katoh, H., Mori, Y., Kambara, H., Abe, T., Fukuhara, T., Morita, E., Moriishi, K., Matsuura, Y., Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA (2011) J. Virol, 85, pp. 10976-10988
• Shih, S.R., Stollar, V., Li, M.L., Host factors in enterovirus 71 replication (2011) J. Virol, 85, pp. 9658-9666
• Monette, A., Ajamian, L., López-Lastra, M., Mouland, A.J., Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: Implications for HIV-1 gene expression (2009) J. Biol. Chem, 284, pp. 31350-31362
• Shabman, R.S., Gulcicek, E.E., Stone, K.L., Basler, C.F., The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import (2011) J. Infect. Dis, 204, pp. S904-S910
• Jahrling, P.B., Hesse, R.A., Rhoderick, J.B., Elwell, M.A., Moe, J.B., Pathogenesis of a Pichinde virus strain adapted to produce lethal infections in guinea pigs (1981) Infect. Immun, 32, pp. 872-880
• Bowick, G.C., Spratt, H.M., Hogg, A.E., Endsley, J.J., Wiktorowicz, J.E., Kurosky, A., Luxon, B.A., Herzog, N.K., Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection (2009) J. Virol, 83, pp. 687-700
• Lukashevich, I.S., Djavani, M., Rodas, J.D., Zapata, J.C., Usborne, A., Emerson, C., Mitchen, J., Salvato, M.S., Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus (2002) J. Med. Virol, 67, pp. 171-186
• Lukashevich, I.S., Rodas, J.D., Tikhonov, I.I., Zapata, J.C., Yang, Y., Djavani, M., Salvato, M.S., LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration (2004) Arch. Virol, 149, pp. 2319-2336
• Djavani, M.M., Crasta, O.R., Zapata, J.C., Fei, Z., Folkerts, O., Sobral, B., Swindells, M., Pauza, C.D., Early blood profiles of virus infection in a monkey model for Lassa fever (2007) J. Virol, 81, pp. 7960-7973
• Maeto, C.A., Knott, M.E., Linero, F.N., Ellenberg, P.C., Scolaro, L.A., Castilla, V., Differential effect of acute and persistent Junin virus infections on the nucleo-cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B (2011) J. Gen. Virol, 92, pp. 2181-2190
• Ellenberg, P., Edreira, M., Lozano, M., Scolaro, L., Synthesis and expression of viral antigens in Vero cells persistently infected with Junin virus (2002) Arch. Virol, 147, pp. 1543-1557
• Ellenberg, P., Edreira, M., Scolaro, L., Resistance to superinfection of Vero cells persistently infected with Junin virus (2004) Arch. Virol, 149, pp. 507-522
• Keating, J.A., Striker, R., Phosphorylation events during viral infections provide potential therapeutic targets (2012) Rev. Med. Virol, 22, pp. 166-181
• Dissmeyer, N., Schnittger, A., The age of protein kinases (2011) Methods Mol. Biol, 779, pp. 7-52
• Buchkovich, N.J., Yu, Y., Zampieri, C.A., Alwine, J.C., The TORrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway (2008) Nat. Rev. Microbiol, 6, pp. 266-275
• Cooray, S., The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival (2004) J. Gen. Virol, 85, pp. 1065-1076
• Ji, W.T., Liu, H.J., PI3K-Akt signaling and viral infection (2008) Recent. Pat. Biotechnol, 2, pp. 218-226
• McCormick, F., Cancer: Survival pathways meet their end (2004) Nature, 428, pp. 267-269
• Zhang, X., Tang, N., Hadden, T.J., Rishi, A.K., Akt, FoxO and regulation of apoptosis (2011) Biochim. Biophys. Acta, 181, pp. 31978-31986
• Linero, F.N., Scolaro, L.A., Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junín virus replication in vitro (2009) Virus Res, 145, pp. 166-170
• Radoshitzky, S.R., Abraham, J., Spiropoulou, C.F., Kuhn, J.H., Nguyen, D., Li, W., Nagel, J., Andrews, N.C., Transferrin receptor 1 is a cellular receptor for New World hemorrhagic fever arenaviruses (2007) Nature, 446, pp. 92-96
• Ruggiero, T., Trabucchi, M., Ponassi, M., Corte, G., Chen, C.Y., Al-Haj, L., Khabar, K.S., Gherzi, R., Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling (2007) BMC Mol. Biol, 8, pp. 281-2815
• Cao, W., Henry, M.D., Borrow, P., Yamada, H., Elder, J.H., Ravkov, E.V., Nichol, S.T., Oldstone, M.B., Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus (1998) Science, 282, pp. 2079-2081
• Pasqual, G., Rojek, J.M., Masin, M., Chatton, J.Y., Kunz, S., Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport (2011) PLoS Pathog, 7, pp. e1002232
• Urata, S., Ngo, N., de la Torre, J.C., The PI3K/Akt pathway contributes to arenavirus budding (2012) J. Virol, 86, pp. 4578-4585
• Sullivan, J.A., Kim, E.H., Plisch, E.H., Peng, S.L., Suresh, M., FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms (2012) PLoS Pathog, 8, pp. e1002533
• Pleschka, S., RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade (2008) Biol. Chem, 389, pp. 1273-1282
• Vela, E.M., Bowick, G.C., Herzog, N.K., Aronson, J.F., Genistein treatment of cells inhibits arenavirus infection (2008) Antivir. Res, 77, pp. 153-156
• Rojek, J.M., Moraz, M.L., Pythoud, C., Rothenberger, S., van der Goot, F.G., Campbell, K.P., Kunz, S., Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan (2012) Cell. Microbiol, 14, pp. 1122-1134
• Vela, E.M., Bowick, G.C., Herzog, N.K., Aronson, J.F., Exploring kinase inhibitors as therapies for human arenavirus Infections (2008) Future Virol, 3, pp. 243-251
• Castilla, V., Merisch, S., Low pH-induced fusion of Vero cells infected with Junin virus (1996) Arch Virol, 141, pp. 1307-1317
• Di Simone, C., Zandonatti, M., Buchmeier, M., Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike (1994) Virology, 198, pp. 455-465
• Di Simone, C., Buchmeier, M., Kinetics and pH dependence of acid-induced structural changes in the Lymphoytic choriomeningitis virus glycoprotein complex (1995) Virology, 209, pp. 3-9
• Borrow, P., Oldstone, M.B., Mechanism of lymphocytic choriomeningitis virus entry into cells (1994) Virology, 198, pp. 1-9
• Shah, W.A., Peng, H., Carbonetto, S., Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via {alpha}-dystroglycan (2006) J. Gen. Virol, 87, pp. 673-678
• Quirin, K., Eschli, B., Scheu, I., Poort, L., Kartenbeck, J., Helenius, A., Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes (2008) Virology, 378, pp. 21-33
• Rojek, J.M., Perez, M., Kunz, S., Cellular entry of lymphocytic choriomeningitis virus (2008) J. Virol, 82, pp. 1505-1517
• Rojek, J.M., Sanchez, A.B., Nguyen, N.T., de la Torre, J.C., Kunz, S., Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses (2008) J. Virol, 82, pp. 7677-7687
• Martinez, M.G., Cordo, S.M., Candurra, N.A., Characterization of JUNV arenavirus cell entry (2007) J. Gen. Virol, 88, pp. 1776-1784
• Vela, E.M., Colpitts, T.M., Zhang, L., Davey, R.A., Aronson, J.F., Pichinde virus is trafficked through a dynamin 2 endocytic pathway that is dependent on cellular Rab5-and Rab7-mediated endosomes (2008) Arch. Virol, 153, pp. 1391-1396
• Martínez, M.G., Forlenza, M.B., Candurra, N.A., Involvement of cellular proteins in Junin arenavirus entry (2009) Biotechnol. J, 4, pp. 866-870. , Martinez MG, Forlenza MB, Candurra NA
• Lee, A.M., Pasquato, A., Kunz, S., Novel approaches in anti-arenaviral drug development (2011) Virology, 411, pp. 163-169
• Kolokoltsov, A.A., Adhikary, S., Garver, J., Johnson, L., Davey, R.A., Vela, E.M., Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin (2012) Arch. Virol, 157, pp. 121-712
• Thomsen, A.R., Nansen, A., Andreasen, S.O., Wodarz, D., Christensen, J.P., Host factors influencing viral persistence (2000) Philos. Trans. R. Soc. Lond. B. Biol. Sci, 355, pp. 1031-1041
• Zuniga, E.I., Hahm, B., Oldstone, M.B., Type I interferon during viral infections: Multiple triggers for a multifunctional mediator (2007) Curr. Top. Microbiol. Immunol, 316, pp. 337-357
• Borrow, P., Martínez-Sobrido, L., de la Torre, J.C., Inhibition of the type I interferon antiviral response during arenavirus infection (2010) Viruses, 2, pp. 2443-2480
• Cuevas, C.D., Lavanya, M., Wang, E., Ross, S.R., Junin virus infects mouse cells and induces innate immune responses (2011) J. Virol, 85, pp. 11058-11068
• Baize, S., Pannetier, D., Faure, C., Marianneau, P., Marendat, I., Georges-Courbot, M.C., Deubel, V., Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages (2006) Microbes Infect, 8, pp. 1194-1202
• Martínez-Sobrido, L., Zúñiga, E.I., Rosario, D., García-Sastre, A., de la Torre, J.C., Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus (2006) J. Virol, 80, pp. 9192-9199
• Martínez-Sobrido, L., Giannakas, P., Cubitt, B., García-Sastre, A., de la Torre, J.C., Differential inhibition of type I interferon induction by arenavirus nucleoproteins (2007) J. Virol, 81, pp. 12696-12703
• Pythoud, C., Rodrigo, W.W., Pasqual, G., Rothenberger, S., Martínez-Sobrido, L., de la Torre, J.C., Kunz, S., Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKK{varepsilon} (2012) J. Virol, 86, pp. 7728-7738
• Rodrigo, W.W., Ortiz-Riaño, E., Pythoud, C., Kunz, S., de la Torre, J.C., Martínez-Sobrido, L., Arenavirus nucleoproteins prevent activation of nuclear factor kappa B (2012) J. Virol, 86, pp. 8185-8197
• Fan, L., Briese, T., Lipkin, W.I., Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction (2010) J. Virol, 84, pp. 1785-1791
• Pindel, A., Sadler, A., The role of protein kinase R in the interferon response (2011) J. Interferon Cytokine Res, 31, pp. 59-70
• Montero, H., Trujillo-Alonso, V., Stress granules in the viral replication cycle (2011) Viruses, 3, pp. 2328-2338
• Linero, F.N., Thomas, M.G., Boccaccio, G.L., Scolaro, L.A., Junin virus infection impairs stress-granule formation in Vero cells treated with arsenite via inhibition of eIF2 alpha phosphorylation (2011) J. Gen. Virol, 92, pp. 2889-2899
• Brostrom, C.O., Prostko, C.R., Kaufman, R.J., Brostrom, M.A., Inhibition of translational initiation by activators of the glucose-regulated stress protein and heat shock protein stress response systems. Role of the interferon-inducible double-stranded RNA-activated eukaryotic initiation factor alpha kinase (1996) J. Biol. Chem, 271, pp. 24995-25002
• Cuevas, C.D., Lavanya, M., Wang, E., Ross, S.R., Junin virus infects mouse cells and induces innate immune responses (2011) J Virol, 85, pp. 11058-11068
• Oliveira-Nascimento, L., Massari, P., Wetzler, L.M., The Role of TLR2 in Infection and Immunity (2012) Front. Immunol, 3, p. 79
• Zhou, S., Kurt-Jones, E.A., Mandell, L., Cerny, A., Chan, M., Golenbock, D.T., Finberg, R.W., MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection (2005) Eur. J. Immunol, 35, pp. 822-830
• Zhou, S., Halle, A., Kurt-Jones, E.A., Cerny, A.M., Porpiglia, E., Rogers, M., Golenbock, D.T., Finberg, R.W., Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses (2008) J. Neuroimmunol, 194, pp. 70-82
• Zhou, S., Cerny, A.M., Bowen, G., Chan, M., Knipe, D.M., Kurt-Jones, E.A., Finberg, R.W., Discovery of a novel TLR2 signaling inhibitor with anti-viral activity (2010) Antivir. Res, 87, pp. 295-306
• Hayes, M.W., Carrion Jr., R., Nunneley, J., Medvedev, A.E., Salvato, M.S., Lukashevich, I.S., Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro (2012) J. Virol, 86, pp. 7216-7226
• Bieniasz, P.D., Intrinsic immunity: A front-line defense against viral attack (2004) Nat. Immunol, 5, pp. 1109-1115
• Tavalai, N., Stamminger, T., New insights into the role of the subnuclear structure ND10 for viral infection (2008) Biochim. Biophys. Acta, 1783, pp. 2207-2221
• Wolf, D., Goff, S.P., Host restriction factors blocking retroviral replication (2008) Annu. Rev. Genet, 42, pp. 143-163
• Hinson, E.R., Joshi, N.S., Chen, J.H., Rahner, C., Jung, Y.W., Wang, X., Kaech, S.M., Cresswell, P., Viperin is highly induced in neutrophils and macrophages during acute and chronic lymphocytic choriomeningitis virus infection (2010) J. Immunol, 184, pp. 5723-5731
• Sakuma, T., Sakurai, A., Yasuda, J., Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses (2009) PLoS One, 4, pp. e6934
• Radoshitzky, S.R., Dong, L., Chi, X., Clester, J.C., Retterer, C., Spurgers, K., Kuhn, J.H., Kota, K., Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin (2010) J. Virol, 84, pp. 10569-10580
• Everett, R.D., Chelbi-Alix, M.K., PML and PML nuclear bodies: Implications in antiviral defence (2007) Biochimie, 89, pp. 819-830
• Bernardi, R., Pandolfi, P.P., Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies (2007) Nat. Rev. Mol. Cell Biol, 8, pp. 1006-1016
• Borden, K.L., Culjkovic, B., Perspectives in PML: A unifying framework for PML function (2009) Front. Biosci, 14, pp. 497-509
• Lang, M., Jegou, T., Chung, I., Richter, K., Münch, S., Udvarhelyi, A., Cremer, C., Hell, S.W., Three-Dimensional organization of promyelocytic leukemia nuclear bodies (2010) J. Cell Sci, 123, pp. 392-400
• Dyck, J.A., Maul, G.G., Miller Jr., W.H., Chen, J.D., Kakizuka, A., Evans, R.M., A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein (1994) Cell, 76, pp. 333-343
• Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., Grosveld, F., Dejean, A., The acute promyelocytic leukaemia-associated PML gene is induced by interferon (1995) Oncogene, 11, pp. 871-876
• Chee, A.V., Lopez, P., Pandolfi, P.P., Roizman, B., Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects (2003) J. Virol, 77, pp. 7101-7105
• Regad, T., Chelbi-Alix, M.K., Role and fate of PML nuclear bodies in response to interferon and viral infections (2001) Oncogene, 20, pp. 7274-7286
• Borden, K.L., Campbell Dwyer, E.J., Salvato, M.S., An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm (1998) J. Virol, 72, pp. 758-766
• García, C.C., Topisirovic, I., Djavani, M., Borden, K.L., Damonte, E.B., Salvato, M.S., An antiviral disulfide compound blocks interaction between arenavirus Z protein and cellular promyelocytic leukemia protein (2010) Biochem. Biophys. Res. Commun, 393, pp. 625-630
• Borden, K.L., Campbell Dwyer, E.J., Salvato, M.S., The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain (1997) FEBS Lett, 418, pp. 30-34
• Djavani, M., Rodas, J., Lukashevich, I.S., Horejsh, D., Pandolfi, P.P., Borden, K.L., Salvato, M.S., Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus (2001) J. Virol, 75, pp. 6204-6208
• Bonilla, W.V., Pinschewer, D.D., Klenerman, P., Rousson, V., Gaboli, M., Pandolfi, P.P., Zinkernagel, R.M., Hengartner, H., Effects of promyelocytic leukemia protein on virus-host balance (2002) J. Virol, 76, pp. 3810-3818
• El McHichi, B., Regad, T., Maroui, M.A., Rodriguez, M.S., Aminev, A., Gerbaud, S., Escriou, N., Chelbi-Alix, M.K., SUMOylation promotes PML degradation during encephalomyocarditis virus infection (2010) J. Virol, 84, pp. 11634-11645

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------